X-Rx is actively seeking potential licensing and collaboration opportunities to advance its programs into clinical trials and beyond.
Building on our partnering success, we are interested in partners with complementary capabilities and a strong track record of developing and commercializing therapies for difficult to treat diseases, in particular inflammation, fibrosis and oncology.
X-Rx is committed to working with potential partners to identify and implement creative deal structures that meet our mutual needs and strategic objectives. We’re confident that our platforms, competencies and experience in biopharma R&D and program / alliance management will bring significant value to our partners and help them meet their therapeutic area and pipeline goals.
To discuss potential partnering opportunities, please contact Ed Koval, our head of business development.